Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)

被引：1
|
作者：
Furqan, M. [1 ]
Zhang, J. [1 ]
Clamon, G. [1 ]
Abu-Hejleh, T. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Med, Iowa City, IA 52242 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Gemcitabine; nab-paclitaxel; small cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.1378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-02
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [21] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas
    Metts, Jonathan L.
    Alazraki, Adina L.
    Clark, Dana
    Amankwah, Ernest K.
    Wasilewski-Masker, Karen J.
    George, Bradley A.
    Olson, Thomas A.
    Cash, Thomas
    PEDIATRIC BLOOD & CANCER, 2018, 65 (09)
  • [23] Phase II study of nab-paclitaxel plus carboplatin for patients with non-small-cell lung cancer and interstitial lung disease
    Kenmotsu, Hirotsugu
    Yoh, Kiyotaka
    Mori, Keita
    Ono, Akira
    Baba, Tomohisa
    Fujiwara, Yutaka
    Yamaguchi, Ou
    Ko, Ryo
    Okamoto, Hiroaki
    Yamamoto, Nobuyuki
    Ninomiya, Takashi
    Ogura, Takashi
    Kato, Terufumi
    CANCER SCIENCE, 2019, 110 (12) : 3738 - 3745
  • [24] A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer
    Hasegawa, Takaaki
    Futamura, Yohei
    Horiba, Akane
    Yoshida, Tsutomu
    Suzuki, Toshitaka
    Kato, Tatsuo
    Kaito, Daizo
    Ohno, Yasuhi
    Iida, Takayoshi
    Hayashi, Shinya
    Sawa, Toshiyuki
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (01) : 50 - 54
  • [25] The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer
    Andrew P. Barbour
    Jaswinder S. Samra
    Koroush S. Haghighi
    Mark W. Donoghoe
    Matthew Burge
    Marion T. Harris
    Yu Jo Chua
    Jenna Mitchell
    Nick O’Rourke
    Howard Chan
    Val J. Gebski
    Sivakumar Gananadha
    Daniel G. Croagh
    James G. Kench
    David Goldstein
    Annals of Surgical Oncology, 2020, 27 : 2506 - 2515
  • [26] The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer
    Barbour, Andrew P.
    Samra, Jaswinder S.
    Haghighi, Koroush S.
    Donoghoe, Mark W.
    Burge, Matthew
    Harris, Marion T.
    Chua, Yu Jo
    Mitchell, Jenna
    O'Rourke, Nick
    Chan, Howard
    Gebski, Val J.
    Gananadha, Sivakumar
    Croagh, Daniel G.
    Kench, James G.
    Goldstein, David
    Barbour, A.
    Goldstein, D.
    Samra, J. S.
    Harris, M.
    Chua, Y. J.
    Burge, M.
    O'Rourke, N.
    Yip, S.
    Gebski, V
    Simes, J.
    Hicks, R.
    Coates, A.
    Gurney, H.
    Do, V
    Marschner, I
    Mitchell, J.
    Donoghoe, M.
    Goldstone, S.
    Pavlakis, N.
    Aghmesheh, M.
    Joubert, W.
    Grimes, D.
    Samra, S.
    Haghighi, K. S.
    Truskett, P.
    Bagia, S.
    Jaber, M.
    Gananadha, S.
    ORourke, N.
    Bryant, R.
    Nathanson, L.
    Cavallucci, D.
    Fawcett, J.
    O'Rourke, T.
    Croagh, D.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2506 - 2515
  • [27] Clinical outcomes of nab-paclitaxel for advanced or relapsed non-small cell lung cancer patients
    Manabe, Saki
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Yamada, Kouzo
    ANNALS OF ONCOLOGY, 2015, 26 : 124 - 124
  • [28] The phase II study of nab-paclitaxel for relapsed NSCLC (NLCTG1302)
    Tanaka, Tomohiro
    Shoji, Satoshi
    Nozaki, Koichiro
    Miura, Satoru
    Watanabe, Satoshi
    Ishida, Takashi
    Tsukada, Hiroki
    Sato, Kazuhiro
    Hiura, Toru
    Okajima, Masaaki
    Ichikawa, Kosuke
    Abe, Tetsuya
    Tanaka, Hiroshi
    Yoshizawa, Hirohisa
    Kikuchi, Toshiaki
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    BMC Cancer, 17
  • [30] A PHASE I STUDY OF NAB-PACLITAXEL COMBINED WITH GEMCITABINE FOR PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS
    Metts, Jonathan
    Ginn, Kevin
    Cost, Carrye
    Froug, Brittani
    Watt, Amanda
    Schink, Melissa
    Senn, Stacy
    Cash, Thomas
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S319 - S320
12345